Literature DB >> 2539852

Human T-lymphoblast deoxycytidine kinase: purification and properties.

N S Datta1, D S Shewach, M C Hurley, B S Mitchell, I H Fox.   

Abstract

Previous observations present tremendous variations in the properties of deoxycytidine kinase. To clarify the properties and physiologic role of deoxycytidine kinase, we have undertaken its purification. Deoxycytidine kinase was purified from cultured human T-lymphoblasts (MOLT-4) to 90% purity with an estimated specific activity of 8 mumol min-1 (mg of protein)-1. The purification procedure included ammonium sulfate precipitation, Superose-12 HPLC gel filtration chromatography, DE-52 ion-exchange chromatography, AMP-Sepharose 4B affinity chromatography, and dCTP-Sepharose-4B affinity chromatography. Deoxyguanosine, deoxyadenosine, and cytidine phosphorylating activities copurified with deoxycytidine kinase to final specific activities of 7.2, 13.5, and 4 mumol min-1 (mg of protein)-1, respectively. The enzyme is very unstable at low protein concentration and is stabilized by storage at -85 degrees C with 1 mg/mL bovine serum albumin, 20% glycerol (v/v), 200 mM potassium chloride, and 25 mM dithiothreitol. The molecular weight was 60,000, and the Stokes radius was 32 A by gel filtration chromatography. The subunit molecular weight was 30,500. This enzyme had apparent Km values of 1.5, 430, 500, 450, and 40 microM for deoxycytidine, deoxyguanosine, deoxyadenosine, cytidine, and cytosine arabinoside, respectively. The pH optimum ranged from 6.5 to 9.0. Mg2+ and Mn2+ were the preferred divalent cations. ATP, GTP, dGTP, ITP, dITP, TTP, and XTP were substrates for the enzymes. Our study indicates that deoxycytidine kinase is a dimer with two subunits and has phosphorylating activity for deoxyguanosine, deoxyadenosine, cytidine, and cytosine arabinoside. This highly purified enzyme will facilitate the study of its regulation and phosphorylation of anticancer or antiviral nucleoside analogues.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2539852     DOI: 10.1021/bi00427a017

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Cellular delivery of nucleoside diphosphates: a prodrug approach.

Authors:  S H Kang; A K Sinhababu; J G Cory; B S Mitchell; D R Thakker; M J Cho
Journal:  Pharm Res       Date:  1997-06       Impact factor: 4.200

2.  In vitro-induced resistance to the deoxycytidine analogues cytarabine (AraC) and 5-aza-2'-deoxycytidine (DAC) in a rat model for acute myeloid leukemia is mediated by mutations in the deoxycytidine kinase (dck) gene.

Authors:  A P Stegmann; M W Honders; A Hagemeijer; B Hoebee; R Willemze; J E Landegent
Journal:  Ann Hematol       Date:  1995-07       Impact factor: 3.673

3.  Characterization of the deoxycytidine kinase promoter in human lymphoblast cell lines.

Authors:  E H Chen; E E Johnson; S M Vetter; B S Mitchell
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

4.  Cloning of human adenosine kinase cDNA: sequence similarity to microbial ribokinases and fructokinases.

Authors:  J Spychala; N S Datta; K Takabayashi; M Datta; I H Fox; T Gribbin; B S Mitchell
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

5.  Human thymidine kinase can functionally replace herpes simplex virus type 1 thymidine kinase for viral replication in mouse sensory ganglia and reactivation from latency upon explant.

Authors:  S H Chen; W J Cook; K L Grove; D M Coen
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

Review 6.  New targets for pyrimidine antimetabolites for the treatment of solid tumours. 2: Deoxycytidine kinase.

Authors:  V W Ruiz van Haperen; G J Peters
Journal:  Pharm World Sci       Date:  1994-04-15

7.  Cloning and expression of human deoxycytidine kinase cDNA.

Authors:  E G Chottiner; D S Shewach; N S Datta; E Ashcraft; D Gribbin; D Ginsburg; I H Fox; B S Mitchell
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

8.  Semi-Automated High-Throughput Substrate Screening Assay for Nucleoside Kinases.

Authors:  Katja F Hellendahl; Maryke Fehlau; Sebastian Hans; Peter Neubauer; Anke Kurreck
Journal:  Int J Mol Sci       Date:  2021-10-26       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.